Assembling the brain trust: the multidisciplinary imperative in neuro-oncology
Ethan B. Ludmir(The University of Texas MD Anderson Cancer Center), Rolf‐Dieter Kortmann(University of Turin), Arnold C. Paulino(The University of Texas MD Anderson Cancer Center), Thomas E. Merchant(St. Jude Children's Research Hospital), Nicky Thorp, Torunn I. Yock(Massachusetts General Hospital), Vinai Gondi(Thomas Jefferson University Hospital), Susan L. McGovern(Northwestern University), Jeannette Parkes(University of Cape Town), C. Carrié(Princess Margaret Cancer Centre), Karen J. Marcus(Harvard University), Luís Souhami(McGill University Health Centre), Thankamma Ajithkumar(University of Cambridge), Stéphanie Bolle(Institut Gustave Roussy), Rakesh Jalali(Tata Memorial Hospital), Mechthild Krause(Helmholtz-Zentrum Dresden-Rossendorf), Gail Horan(Queen Elizabeth Hospital King's Lynn NHS Foundation Trust), David R. Grosshans(The University of Texas MD Anderson Cancer Center), Greg Wheeler(Peter MacCallum Cancer Centre), Ranjit S. Bindra(Yale University), Lorenza Gandola(Fondazione IRCCS Istituto Nazionale dei Tumori), Helen A. Shih(Massachusetts General Hospital), Valérie Bernier‐Chastagner(Institut de Cancérologie de Lorraine), Karin Dieckmann(University of Vienna), Erik P. Sulman(NYU Langone Health), Beate Timmermann(Essen University Hospital), Eric L. Chang(Keck Hospital of USC), Anita Mahajan(Mayo Clinic in Arizona), Amol J. Ghia(The University of Texas MD Anderson Cancer Center), Verity Ahern(Westmead Hospital), Paul D. Brown(Mayo Clinic), Normand Laperrière(University Health Network), Anthony J. Chalmers(Beatson West of Scotland Cancer Centre), Nadia N. Laack(Mayo Clinic), Claire Alapetite(Institut d’Hématologie et d’Oncologie Pédiatrique), Suzanne L. Wolden(Memorial Sloan Kettering Cancer Center), Caroline Chung(University of California, Los Angeles), Natia Esiashvili(Emory University), Geert O. Janssens(University Medical Center Utrecht), Laëtitia Padovani(Inserm), D.N. Yeboa(The University of Texas MD Anderson Cancer Center), Kenneth W. Merrell(Mayo Clinic), Jing Li(Tufts Medical Center), A. Laprie(Institut Claudius Regaud), Roger Taylor(Swansea University), Kristina D. Woodhouse(The University of Texas MD Anderson Cancer Center), Semi Harrabi(Heidelberg University), Rudolf Schwarz(Universität Hamburg), Andrew J. Bishop(The University of Texas MD Anderson Cancer Center)
Cited by 5
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k